coronavirus vaccine Archives

SAN Stock Up 0.52%, Sanofi to Begin Human Trials of Second COVID-19 Vaccine

Sanofi will begin testing its second COVID-19 vaccine on 415 people today. First results are expected sometime between July and September 2021.

Nasdaq Composite Climbs to New High on Stimulus Package and Vaccine Optimism

Business News, Indices, Market News, News, Stocks

By Darya Rudz Feb 9, 2021

Wall Street’s rally has resulted mostly from investors’ bet on a new fiscal relief package and a global vaccine roll-out that could lead to a faster economic recovery.

AstraZeneca Vaccine Appears Less Effective against COVID-19 in South Africa

Business News, Market News, News, Stocks, Wall Street

By Ibukun Ogundare Feb 8, 2021

At press time, AstraZeneca stock is at $50 in the pre-market trading, which shows a 0.54% increase over its previous close of $49.73.

Business News, Market News, News, Stocks

MRNA Stock Shoots 12% on Monday as Moderna Says Its Vaccine Will Work on New COVID Strains

By Bhushan Akolkar Jan 26, 2021

Moderna’s top-executives have assured that the vaccine would be effective to a certain degree on the new mutations. However, they are willing to see more results under different conditions. Moderna has received a positive review from field experts as well!

Business News, Editor's Choice, Market News, News, Stocks

Tech Shares Soar as Tech Giants Are Expected to Report Q4 Earnings

By Darya Rudz Jan 25, 2021

According to Chuck Carlson, CEO at Horizon Investment Services, the upcoming reports could help determine whether the resurgence in growth stocks will continue.

Business News, Market News, News, Stocks, Wall Street

MRNA Stock Down 3.58%, Moderna Studies Allergic Reactions to Its Vaccine

By Steve Muchoki Jan 20, 2021

With the existence of huge global demand for the vaccine, Moderna stock is expected to rally further in the coming quarters.

Business News, Deals News, Market News, News, Technology News

Moderna and Uber Partner on COVID-19 Vaccine Access

By Mercy Tukiya Mutanya Jan 13, 2021

Engaging an app with a wide reach like Uber to the initiative could help counter the negative impact of the misinformation.

Business News, Market News, News, Stocks

AZN Stock Jumps 3% as UK Begins Rollout of Oxford-AstraZeneca COVID-19 Vaccine

By Godfrey Benjamin Jan 4, 2021

The AstraZeneca (AZN) shares are up today with investors bearing the sentiment that the stock will witness an improved performance thanks to the obvious advantages the Oxford-AZN vaccine has over its rivals.

Business News, Market News, News, Stocks, Wall Street

AZN Stock Up 4% in Pre-Market as AstraZeneca Vaccine Nears UK Approval

By John K. Kumi Dec 28, 2020

Pascal Soriot, the Chief Executive of AstraZeneca revealed that the vaccine is as effective as Pfizer and can be a strong protector against the new variant of the virus which is very contagious.

Business News, Market News, News, Stocks

PFE Stock Rises on FDA Authorization Pfizer COVID-19 Vaccine for Emergency Use, US to Immunize 100 Million by End of March

By Darya Rudz Dec 14, 2020

According to the FDA, Pfizer’s COVID-19 vaccine is given as two shots administered 21 days apart. One dose is to prime the body, and then a few weeks later, the second dose is to boost the response.

Business News, Market News, News

FDA Approves Pfizer Vaccine, 3 Million Doses to Ship in a Week

By Steven Msoh Dec 12, 2020

The Food and Drug Administration has approved the Pfizer COVID-19 vaccine, paving way for close to three million highly-vulnerable Americans to receive the vaccine next week.

Business News, Market News, News, Stocks

Pfizer (PFE) Vaccine Now Administered in UK, First Person Gets Vaccine Outside Trial

By Godfrey Benjamin Dec 8, 2020

While the Pfizer (PFE) vaccine is the first of the vaccines expected to get regulatory approval this year, its distribution may be limited considering its extremely low storage and distribution temperature of minus 70 degrees Celsius and below.

Business News, Market News, News, Stocks

Pfizer and BioNTech COVID-19 Vaccine Approved for Use by UK

By John K. Kumi Dec 2, 2020

The Pfizer and BioNTech COVID-19 vaccine is now clinically safe and would be made available for use by next week with priority given to the most vulnerable group.

Business News, Editor's Choice, Market News, News

AstraZeneca Vaccine Shows Efficacy of Up to 90%

By John K. Kumi Nov 23, 2020

One of the regimens came out with 62% efficacy when administered for one month apart in two full doses. The other dosing regimen came out with an efficacy rate of 90% when administered for at least a month apart with a half dose followed by a full dose.

Business News, Market News, News, Stocks

CureVac Prepares Facility to 300 Million COVID-19 Vaccine Doses in 2021

By Bhushan Akolkar Nov 18, 2020

As CureVac prepares to push its COVID-19 vaccine candidate in the final stage of trials, it is also working on a pan-EU network to manufacture millions of the vaccine doses.